← Back to Clinical Trials
Recruiting NCT05991154

NCT05991154 JoyPop Mobile Mental Health App With Indigenous Transitional-Aged Youth

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05991154
Status Recruiting
Phase
Sponsor Lakehead University
Condition Emotion Regulation
Study Type INTERVENTIONAL
Enrollment 110 participants
Start Date 2023-08-11
Primary Completion 2025-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 25 Years
Study Type INTERVENTIONAL
Interventions
Usual Practice + JoyPop

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 110 participants in total. It began in 2023-08-11 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Indigenous youth in Northwestern Ontario who need mental health supports experience longer waits than non-Indigenous youth within the region and when compared to youth in other more urban areas. Limited access and extended waits can exacerbate symptoms, prolong distress, and increase risk for more serious outcomes. Transitional aged youth (i.e., those in their mid-late teens to early twenties) are a particularly vulnerable group. Novel, innovative approaches are urgently needed to provide support for Indigenous youth in Northwestern Ontario. In partnership with Dilico Anishinabek Family Care, the investigators are evaluating the impact of a mental health app (JoyPop) as a tool for Indigenous transitional-aged youth who are waiting for mental health services. The JoyPop app was developed to support improved emotion regulation - a key difficulty for youth presenting with mental health challenges. A two-arm randomized controlled trial (RCT) will be used to evaluate the effectiveness of the app compared to usual practice while Indigenous transitional-aged youth are waiting for mental health services.

Eligibility Criteria

Inclusion Criteria: * Indigenous transitional-aged youth must be on the wait-list for mental health services at Dilico Anishinabek Family Care and be between 18-25 years old. * Eligible youth will also need to be available to attend a virtual or in-person orientation session. * In order to download the JoyPop app, participants will need access to an iOS device (e.g., iPhone, iPad). Refurbished iPhones containing just the JoyPop app will be provided to participants to use for the duration of the trial if they do not have access to their own.

Contact & Investigator

Central Contact

Aislin R Mushquash, Ph.D.

✉ aislin.mushquash@lakeheadu.ca

📞 807-343-8010

Principal Investigator

Aislin R Mushquash, Ph.D.

PRINCIPAL INVESTIGATOR

Lakehead University

Frequently Asked Questions

Who can join the NCT05991154 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 25 Years, studying Emotion Regulation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05991154 currently recruiting?

Yes, NCT05991154 is actively recruiting participants. Contact the research team at aislin.mushquash@lakeheadu.ca for enrollment information.

Where is the NCT05991154 trial being conducted?

This trial is being conducted at Thunder Bay, Canada.

Who is sponsoring the NCT05991154 clinical trial?

NCT05991154 is sponsored by Lakehead University. The principal investigator is Aislin R Mushquash, Ph.D. at Lakehead University. The trial plans to enroll 110 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology